Erwinase®: Clinical Trials

5 trials of Erwinase®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting, 1 completed. 4 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 3, Completed 1
Phase 12Active not recruiting 2
Phase 32Active not recruiting 2

Follow Erwinase®: new trials by email Literature Review of Erwinase® trials Research Report on Erwinase®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Venetoclax, Navitoclax, Dexamethasone - Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingSt. Jude Children's Research Hospital352022-08-252026-10-15
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Prednisone, Vincristine, Daunorubicin - Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
Phase 2 / Phase 3Active not recruitingSt. Jude Children's Research Hospital7902017-03-292026-06-17
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Pegaspargase, Erwinia asparaginase, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric
Phase 3Active not recruitingDana-Farber Cancer Institute5602017-03-032026-07-16
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
ITMHA, Dexamethasone, Mitoxantrone - Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingSt. Jude Children's Research Hospital502016-01-292026-06-24
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
Prednisone, Vincristine, Daunorubicin - Lymphoblastic Lymphoma
Phase 2CompletedSt. Jude Children's Research Hospital232012-05-252022-06-28

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Leukemia (1)  ·  Lymphoma (1)

Sponsors

St. Jude Children's Research Hospital (4)  ·  Dana-Farber Cancer Institute (1)

Countries

United States (5)  ·  Canada (2)  ·  Australia (1)

Top investigators

Hiroto Inaba, MD, PhD (1)  ·  Hiroto Inaba, MD,PhD (1)  ·  Melissa Burns, MD (1)  ·  Seth E. Karol, MD (1)  ·  Sima Jeha, MD (1)  ·  Tanja Gruber, MD, PhD (1)

Results publications

PMID 34933343, PMID 40905823, PMID 41469545, PMID 41692013, PMID 42154791